12 Health Care Stocks Moving In Monday's After-Market Session

Gainers

  • GeneDx Hldgs WGS shares increased by 21.8% to $13.4 during Monday's after-market session. The market value of their outstanding shares is at $349.1 million. The company's, Q1 earnings came out today.
  • InnovAge Holding INNV shares increased by 7.25% to $3.99. The market value of their outstanding shares is at $542.2 million.
  • Mustang Bio MBIO shares increased by 5.48% to $0.25. The market value of their outstanding shares is at $2.5 million.
  • Lucid Diagnostics LUCD stock moved upwards by 5.23% to $0.79. The market value of their outstanding shares is at $38.1 million.
  • Seelos Therapeutics SEEL shares increased by 4.88% to $0.29. The market value of their outstanding shares is at $4.0 million.
  • NewAmsterdam Pharma NAMS shares increased by 4.8% to $22.7. The market value of their outstanding shares is at $2.0 billion.

Losers

  • GlucoTrack GCTK stock declined by 10.7% to $0.5 during Monday's after-market session. The market value of their outstanding shares is at $13.3 million.
  • Vaxxinity VAXX stock decreased by 9.44% to $0.14. The company's market cap stands at $18.1 million.
  • Ekso Bionics Holdings EKSO stock fell 5.43% to $1.22. The market value of their outstanding shares is at $21.8 million. As per the press release, Q1 earnings came out today.
  • Cosmos Health COSM shares declined by 5.0% to $0.67. The company's market cap stands at $11.3 million.
  • Inozyme Pharma INZY stock decreased by 4.98% to $4.2. The market value of their outstanding shares is at $259.4 million.
  • Prenetics Global PRE shares fell 4.73% to $4.24. The market value of their outstanding shares is at $51.7 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!